Cargando…
Expected Impact of Biosimilars on the Pharmaceutical Companies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Shiraz University of Medical Sciences
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438344/ https://www.ncbi.nlm.nih.gov/pubmed/34539015 http://dx.doi.org/10.30476/IJMS.2021.92314.2356 |
| _version_ | 1783752351556829184 |
|---|---|
| author | Golshani, Shiva Ali Faramarzi, Mohammad |
| author_facet | Golshani, Shiva Ali Faramarzi, Mohammad |
| author_sort | Golshani, Shiva |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8438344 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Shiraz University of Medical Sciences |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84383442021-09-17 Expected Impact of Biosimilars on the Pharmaceutical Companies Golshani, Shiva Ali Faramarzi, Mohammad Iran J Med Sci Letter to Editor Shiraz University of Medical Sciences 2021-09 /pmc/articles/PMC8438344/ /pubmed/34539015 http://dx.doi.org/10.30476/IJMS.2021.92314.2356 Text en Copyright: © Iranian Journal of Medical Sciences https://creativecommons.org/licenses/by-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Golshani, Shiva Ali Faramarzi, Mohammad Expected Impact of Biosimilars on the Pharmaceutical Companies |
| title | Expected Impact of Biosimilars on the Pharmaceutical Companies |
| title_full | Expected Impact of Biosimilars on the Pharmaceutical Companies |
| title_fullStr | Expected Impact of Biosimilars on the Pharmaceutical Companies |
| title_full_unstemmed | Expected Impact of Biosimilars on the Pharmaceutical Companies |
| title_short | Expected Impact of Biosimilars on the Pharmaceutical Companies |
| title_sort | expected impact of biosimilars on the pharmaceutical companies |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438344/ https://www.ncbi.nlm.nih.gov/pubmed/34539015 http://dx.doi.org/10.30476/IJMS.2021.92314.2356 |
| work_keys_str_mv | AT golshanishiva expectedimpactofbiosimilarsonthepharmaceuticalcompanies AT alifaramarzimohammad expectedimpactofbiosimilarsonthepharmaceuticalcompanies |